242 related articles for article (PubMed ID: 7053574)
41. Karyotypic changes associated with spontaneous acquisition and loss of tumorigenicity in a human transformed bronchial epithelial cell line: evidence for in vivo selection of transformed clones.
Schiller JH; Bittner G; Wu SQ; Meisner L
In Vitro Cell Dev Biol Anim; 1998 Apr; 34(4):283-9. PubMed ID: 9590501
[TBL] [Abstract][Full Text] [Related]
42. Fusion-induced malignancy? A preliminary study. (a challenge to today's common wisdom).
Munzarová M; Lauerová L; Kovarík J; Rejthar A; Brezina V; Kellnerová R; Kovarík A
Neoplasma; 1992; 39(2):79-86. PubMed ID: 1528312
[TBL] [Abstract][Full Text] [Related]
43. Suppression of malignancy in human cancer cells: issues and challenges.
Sabin AB
Proc Natl Acad Sci U S A; 1981 Nov; 78(11):7129-33. PubMed ID: 6273913
[TBL] [Abstract][Full Text] [Related]
44. Suppression of tumorigenicity of a human lung carcinoma line by nontumorigenic bronchial epithelial cells in somatic cell hybrids.
Kaighn ME; Gabrielson EW; Iman DS; Pauls EA; Harris CC
Cancer Res; 1990 Mar; 50(6):1890-6. PubMed ID: 2306741
[TBL] [Abstract][Full Text] [Related]
45. Tumorigenicity and immunogenicity of somatic cell hybrids between L1210 mouse leukemia cell and L-fibroblast.
Watanabe E; Kawashima K; Isobe K; Yamada K; Saga S; Takahashi T
Nihon Ketsueki Gakkai Zasshi; 1983 Feb; 46(1):121-9. PubMed ID: 6858561
[No Abstract] [Full Text] [Related]
46. Distinction of the phenotypes of in vitro anchorage-independent soft-agar growth and in vivo tumorigenicity in the nude mouse.
Dodson MG; Slota J; Lange C; Major E
Cancer Res; 1981 Apr; 41(4):1441-6. PubMed ID: 7011536
[TBL] [Abstract][Full Text] [Related]
47. The suppression of tumorigenicity in human X mouse cell hybrids. II. The relationship between tumorigenicity and parameters of transformation in vitro.
Chopan M; Kopelovich L
Exp Cell Biol; 1981; 49(3):132-40. PubMed ID: 7195844
[TBL] [Abstract][Full Text] [Related]
48. Expression of malignancy in hybrids between normal and malignant cells.
Croce CM; Barrick J; Linnenbach A; Koprowski H
J Cell Physiol; 1979 Jun; 99(3):279-85. PubMed ID: 457790
[TBL] [Abstract][Full Text] [Related]
49. Suppression of tumorigenicity.
Klinger HP
Cytogenet Cell Genet; 1982; 32(1-4):68-84. PubMed ID: 7140370
[No Abstract] [Full Text] [Related]
50. Transformation of immortal, non-tumorigenic osteoblast-like human osteosarcoma cells to the tumorigenic phenotype by nickel sulfate.
Rani AS; Qu DQ; Sidhu MK; Panagakos F; Shah V; Klein KM; Brown N; Pathak S; Kumar S
Carcinogenesis; 1993 May; 14(5):947-53. PubMed ID: 8504488
[TBL] [Abstract][Full Text] [Related]
51. Suppression of tumorigenicity in hybrids of tumorigenic Chinese hamster cells and diploid mouse fibroblasts: dependence on the presence of at least three different mouse chromosomes and independence of hamster genome dosage.
Schäfer R; Hoffmann H; Willecke K
Cancer Res; 1983 May; 43(5):2240-6. PubMed ID: 6831446
[TBL] [Abstract][Full Text] [Related]
52. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
[TBL] [Abstract][Full Text] [Related]
53. Tumorigenicity of primary mouse fibroblasts transformed by bovine papillomavirus type 1.
Mäntyjärvi R; Sarkkinen H; Parkkinen S; Laatikainen A; Ryhänen A; Syrjänen K
Intervirology; 1988; 29(6):311-9. PubMed ID: 2852654
[TBL] [Abstract][Full Text] [Related]
54. Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells.
Geiser AG; Der CJ; Marshall CJ; Stanbridge EJ
Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5209-13. PubMed ID: 3523486
[TBL] [Abstract][Full Text] [Related]
55. Nonrandom chromosome losses in tumorigenic revertants of hybrids between isogeneic immortal and neoplastic human uroepithelial cells.
Klingelhutz AJ; Wu SQ; Reznikoff CA
Somat Cell Mol Genet; 1991 Nov; 17(6):551-65. PubMed ID: 1767334
[TBL] [Abstract][Full Text] [Related]
56. Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma.
Staroselsky AH; Pathak S; Chernajovsky Y; Tucker SL; Fidler IJ
Cancer Res; 1991 Dec; 51(23 Pt 1):6292-8. PubMed ID: 1834329
[TBL] [Abstract][Full Text] [Related]
57. Loss of tumor-suppressive function during chemically induced neoplastic progression of Syrian hamster embryo cells.
Koi M; Barrett JC
Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5992-6. PubMed ID: 3461473
[TBL] [Abstract][Full Text] [Related]
58. Tumorigenicity of T lymphoma/T lymphoma hybrids and T lymphoma/normal cell hybrids.
Hays EF; Weinroth SE; MacLeod CL; Kitada S
Int J Cancer; 1986 Oct; 38(4):597-601. PubMed ID: 3759264
[TBL] [Abstract][Full Text] [Related]
59. Specific chromosome loss associated with the expression of tumorigenicity in human cell hybrids.
Stanbridge EJ; Flandermeyer RR; Daniels DW; Nelson-Rees WA
Somatic Cell Genet; 1981 Nov; 7(6):699-712. PubMed ID: 7323948
[TBL] [Abstract][Full Text] [Related]
60. Genetic control of tumorigenicity in interspecific mammalian cell hybrids.
Kucherlapati R; Shin SI
Cell; 1979 Mar; 16(3):639-48. PubMed ID: 455444
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
